Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) PT at $16.25

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has been given a consensus rating of "Hold" by the six ratings firms that are presently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $16.25.

A number of equities research analysts recently issued reports on the stock. Macquarie started coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $18.00 price target on the stock. UBS Group upped their price objective on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a "neutral" rating in a report on Tuesday, November 5th. Jefferies Financial Group lifted their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a "buy" rating in a report on Tuesday, November 5th. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday. Finally, Mizuho raised their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th.

Insider Buying and Selling

In other news, EVP Mary Ann E. Moore sold 8,108 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the sale, the executive vice president now owns 135,810 shares of the company's stock, valued at approximately $2,172,960. This represents a 5.63 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total transaction of $423,660.00. Following the transaction, the director now directly owns 138,683 shares of the company's stock, valued at approximately $2,128,784.05. This trade represents a 16.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Pediatrix Medical Group

Institutional investors and hedge funds have recently bought and sold shares of the company. Quest Partners LLC grew its holdings in shares of Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after buying an additional 622 shares during the last quarter. Quarry LP increased its holdings in Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after acquiring an additional 1,662 shares during the last quarter. Canada Pension Plan Investment Board purchased a new position in shares of Pediatrix Medical Group in the second quarter worth about $72,000. CWM LLC raised its holdings in Pediatrix Medical Group by 134.0% during the 3rd quarter. CWM LLC now owns 6,427 shares of the company's stock valued at $74,000 after acquiring an additional 3,681 shares during the period. Finally, Vanguard Personalized Indexing Management LLC purchased a new stake in Pediatrix Medical Group during the 2nd quarter worth about $81,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Price Performance

Shares of MD stock traded up $0.14 during trading hours on Friday, hitting $14.30. The stock had a trading volume of 532,182 shares, compared to its average volume of 400,271. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of -4.67, a PEG ratio of 1.42 and a beta of 1.58. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $16.41. The stock's 50-day moving average price is $14.00 and its two-hundred day moving average price is $12.07.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. During the same period in the previous year, the firm earned $0.29 earnings per share. The business's revenue was up .9% on a year-over-year basis. Equities analysts forecast that Pediatrix Medical Group will post 1.26 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.